AstraZeneca: all 4,196 studies
Page 35 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- ATAC - Quality of Life Sub-ProtocolCompletedNCT00784680Phase 3
- A Study on Intima Media Thickness (IMT) in Middle-aged SubjectsCompletedNCT00784264
- Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function MeasurementsCompletedNCT00783042Early Phase 1
- Antidepressant Incomplete Response DepressionCompletedNCT00782964
- Four Dimensions in SchizophreniaCompletedNCT00782899
- Phase I AZD2281/Cisplatin in Advanced Solid Tumour PatientsCompletedNCT00782574Phase 1
- Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily PracticeCompletedNCT00782314
- AZD6765 Severe Major Depressive Disorder (MDD) IVCompletedNCT00781742Phase 2
- Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment GoalCompletedNCT00781560
- Phase I Comparative Bioavailability StudyActive, not recruitingNCT00777582Phase 1
- Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy VolunteersTerminatedNCT00777361Phase 1
- To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of MetforminCompletedNCT00774553Phase 1
- Assess Safety, Tolerability and PK of AZD3199 in JapaneseCompletedNCT00772759Phase 1
- A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) TreatmentCompletedNCT00772733
- Relative Bioavailability of Phase II and Phase III Formulations of AZD0530CompletedNCT00771979Phase 1
- A Single Dose Study of the CAM-3001 in Patients With Rheumatoid ArthritisCompletedNCT00771420Phase 1
- Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and HypertensionCompletedNCT00771069
- Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of SaxagliptinCompletedNCT00770302Phase 1
- National Survey on AsthmaCompletedNCT00770250
- Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848CompletedNCT00770003Phase 1
- AZD7325 Single Ascending Dose Study in Healthy Male Japanese SubjectsCompletedNCT00769899Phase 1
- The Performance of Patient Support Program in Early Stage Breast CancerCompletedNCT00769080
- Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)CompletedNCT00768443
- Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD PatientsCompletedNCT00768196
- To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of InsulinCompletedNCT00768105Phase 1
- An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily PracticeCompletedNCT00767585
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old ChildrenCompletedNCT00767416Phase 1/2
- Analysis of Antihypertensive Treatment EfficacyTerminatedNCT00767247
- Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236CompletedNCT00767052Phase 1
- Study in Taiwanese Subjects Identified as CYP2C19 Poor and Extensive Metabolizers Receiving RosuvastatinCompletedNCT00766025Phase 1
- Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese SubjectsCompletedNCT00766012Phase 1
- AZD8529 Multiple Ascending Dose Study in Healthy SubjectsCompletedNCT00765492Phase 1
- Non-Interventional Study to Evaluate Effect of Zoladex In EndometrioSISTerminatedNCT00761683
- Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn ECompletedNCT00761501Phase 1
- Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR TreatmentCompletedNCT00758251
- AZD3355 Dose-escalation Study in Healthy MalesCompletedNCT00757419Phase 1
- Treatment Clinical Practice in Bipolar Depression in SpainCompletedNCT00757328
- AZD8529 Single Ascending Dose StudyCompletedNCT00755378Phase 1
- Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy VolunteersCompletedNCT00754715Phase 1
- To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328CompletedNCT00752830Phase 1
- A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCICompletedNCT00751231Phase 2
- Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid TumoursActive, not recruitingNCT00750841Phase 1
- A Sedation/Cognition/EEG Study Using AZD6280 and ComparatorCompletedNCT00750802Phase 1
- Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid TumoursCompletedNCT00750425Phase 1
- Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XRCompletedNCT00750087
- Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With SchizophreniaCompletedNCT00749970
- Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.CompletedNCT00749333Phase 1
- DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)CompletedNCT00748891Phase 1
- A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 DiabetesCompletedNCT00747175Phase 1
- AZD5672 Absolute Bioavailability StudyCompletedNCT00746837Phase 1
- A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque PsoriasisWithdrawnNCT00746434Phase 2
- A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)WithdrawnNCT00746382Phase 2
- Atypical Antipsychotics in Improvement of Quality of Life in Bipolar DisorderCompletedNCT00745966
- A Study to Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy VolunteersCompletedNCT00741689Phase 1
- A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic GoutCompletedNCT00741442Phase 2
- Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)CompletedNCT00739505Phase 1
- Safety, Tolerability & PK of AZD0328 in Caucasian & JapaneseCompletedNCT00738959Phase 1
- Uric Acid Study in Healthy Male VolunteersCompletedNCT00738842Phase 1
- To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese SubjectsCompletedNCT00738322Phase 1
- An Observational Study of Adherence to Anastrozole in Early Breast Cancer TreatmentCompletedNCT00737009
- Assess Safety, Tolerability and Pharmacokinetic (PK) of AZD1704 in Healthy Japanese Male and Non-Fertile Female VolunteersTerminatedNCT00736788Phase 1
- AZD1386 Japanese Multiple Ascending Dosing StudyCompletedNCT00736658Phase 1
- A Study to Assess Co-Administered AZD9056 (Steady State) and Simvastatin (Single Dose) in Healthy VolunteersCompletedNCT00736606Phase 1
- Faslodex Registry: Fulvestrant in Current Clinical PracticeCompletedNCT00735215
- Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive DisorderCompletedNCT00733668Phase 2
- Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy VolunteersCompletedNCT00733265Phase 1
- Depiction of Prostate Cancer Treatment Alternatives in GreeceCompletedNCT00733213
- Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918TerminatedNCT00733031Phase 1
- A Study of Tor Kinase Inhibitor in Advanced TumorsCompletedNCT00731263Phase 1
- Investigating Safety, Tolerability and Pharmakinetics When Giving Single and Fractionated Doses of AZD3241 to Healthy VolunteersCompletedNCT00729443Phase 1
- Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.CompletedNCT00728780Phase 1
- Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer PatientsCompletedNCT00727883
- Renal Mechanism of Action/Splay vs. TmGTerminatedNCT00726505Phase 1
- A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy VolunteersCompletedNCT00726427Phase 1
- To Explore the Treatment Effect of Various Commercially Available Statins on Patients With HyperlipidemiaCompletedNCT00726362
- Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of DigoxinCompletedNCT00723424Phase 1
- Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and AtorvastatinCompletedNCT00722956Phase 1
- European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00722267
- An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing ChemotherapyTerminatedNCT00721981
- An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy VolunteersCompletedNCT00721448Phase 1
- A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.CompletedNCT00720421Phase 1
- Assessment of the Effect of Food on ABT-143 BioavailabilityCompletedNCT00719693Phase 1
- Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.CompletedNCT00717119
- Safety Study of AZD5672 in Renally Impaired SubjectsCompletedNCT00715702Phase 1
- Formulation and Food Effect Study of AZD1386 in Healthy VolunteersCompletedNCT00714337Phase 1
- CARE - Quality Improvement in Asthma Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.CompletedNCT00714038
- CARE - Quality Improvement in Cardiovascular Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.CompletedNCT00713960
- Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets.CompletedNCT00713791Phase 1
- Pharmacokinetic Interaction Between AZD3480 and DonepezilTerminatedNCT00713765Phase 1
- Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc IntervalCompletedNCT00713336Phase 1
- Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy MenCompletedNCT00713271Phase 1
- An Interaction Study With Digoxin and AZD1305CompletedNCT00712465Phase 1
- Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male VolunteersCompletedNCT00711074Phase 1
- Esophageal Hypersensitivity Study in Healthy VolunteersCompletedNCT00711048Phase 1
- Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid MalignanciesCompletedNCT00710515Phase 1
- Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid TumoursCompletedNCT00710268Phase 1
- Food Effect Study of a Single Dose of ZD4054 (Zibotentan)CompletedNCT00710047Phase 1
- Drug Interaction Study to Asses Multiple Doses of ZD4054 (Zibotentan)CompletedNCT00709553Phase 1
- Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast CancerCompletedNCT00707707Phase 1
- An Interaction Study of Ketoconazole/Verapamil Versus AZD1305CompletedNCT00707551Phase 1